Yamanouchi Opens Pharma Plant In USA

Yamanouchi Shaklee Pharma, a branch of Shaklee Corp which is awholly-owned subsidiary of Yamanouchi Pharmaceutical of Japan, has opened its first North American solid- dosage pharmaceutical manufacturing plant in Norman, Oklahoma, USA.

The almost 60,000 square-foot facility will include three production lines, staffed by approximately 150 employees, the first line of which will be dedicated to the manufacturing of Yamanouchi's tamsulosin for the treatment of functional symptoms of benign prostatic hyperplasia. Shigeo Morioka, Yamanouchi's chairman, said that the new site represents a significant advance in the company's strategy of growing in the three major markets of the USA, Japan and Europe.